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The purpose of this study was to evaluate the influence of age on the effectiveness of
rhBMP-7 treatment in a fracture with severe periosteal damage that is known to result in
non-union formation. Closed stabilized femur fractures were produced in 3-month-old
and 18-month-old rats. The fracture site was exposed and 2 mm of the periosteum 
cauterized circumferentially to impair normal fracture healing. The cauterized fracture
site was immediately treated with either 100 mg rhBMP-7 (BMP-7 group), or with 25
xL of vehicle alone (control group). Fracture healing was evaluated with radiographs
taken at 3 and 6 weeks. Animals were sacrificed at 3 and 6 weeks and specimens
subjected to biomechanical and histological evaluation. In both age groups, none of the
control animals healed throughout the 6 weeks experimental duration. All of the 
rhBMP-7–treated 3-month-old animals were radiographically healed at 3 weeks. In
comparison, only 56% (9/16) of the rhBMP-7–treated 18-month-old animals were
radiographically healed at 3 weeks. At 6 weeks, however, all of the 18-month-old
rhBMP-7–treated animals had healed. Histology revealed slower healing in the 18­
month-old animals. Treatment with rhBMP-7 significantly increased all of the
biomechanical properties in both age groups. In the 3-month-old animals the mechanical
strength approached that of the intact femur at 3 weeks, while in the 18-month-old
animals this did not occur until 6 weeks. In conclusion, rhBMP-7 can effectively
stimulate fracture repair in both young (3- month-old) and old (18-month-old) rats.
However, the effect of rhBMP-7 on the rate of fracture healing is greater in young rats
     
 
   
 
   
  
 
  
     
    
 
   
 
 
          
  
 
      
 
 
  
  
    
    
  
 
   
compared to old rats.
INTRODUCTION
The rate of fracture healing is progressively slower with increasing age.1 Older 
patients are at increasing risk for sustaining fractures, with over half of all hospitalizations 
for fractures occurring in patients age 65 and older. The number of older patients 
sustaining fractures is projected to rise dramatically as the overall population lifespan
increases. It is therefore important to improve our understanding of why fracture healing is 
delayed in older patients, and develop treatment measures to counteract those detrimental 
effects.
The ability of bone morphogenetic proteins (BMPs) to enhance fracture healing has 
been examined in numerous animal and clinical stu-dies.2–6 However, to date there have 
been limited in vivo studies that have specifically examined the influence of age on the
effectiveness of BMP treatment. The purpose of this study was to examine whether age 
influences the effectiveness of rhBMP-7 treatment in a fracture with severe peristeal 
disruption that is known to result in nonunion formation.
MATERIALS AND METHODS
Experimental Design
Three-month-old (young) and eighteen-month-old (old) Fisher 344 rats were used in this 
study. The mean body weights were: young, 292 士 46 g; old, 446 士 15 g. All surgical 
procedures were performed under general anesthesia and normal sterile conditions.
Anesthesia was performed with 4% halothane inhalation, followed by ketamine 
hydrochloride (80 mg/kg) and xylazine hydrochloride (8 mg/kg) administered
intraperitoneally.
A lateral parapatellar knee incision on the right limb was made to expose the distal 
femoral condyle. A 1.25-mm diameter K wire was inserted from the trochlear groove into 
the femoral canal in a retrograde fashion with use of a motor-driven drill. The wire was 
advanced through the greater trochanter and out of the skin until its distal end was 
positioned deep to the articular surface of the knee. A 5-mm incision in the skin was made 
around the K wire and the wire was then cut close to the proximal femur. After irrigation 
with sterile saline, the wounds were closed with 4-0 nylon suture. A closed transverse 
femoral shaft fracture was then created in the right femur of each rat using a three-point
bending apparatus with a drop weight.7 In order to produce the non-union, the fractured
site was then exposed through a lateral approach and the periosteum was cauterized (Loop
tip surgical cautery, Abco Dealers Inc., Nashville, TN) circumferentially for a distance of 2
mm on each side of the fracture. The muscle was protected to preserve all soft tissue except 
  
  
     
  
         
    
  
   
    
   
 
 
     
   
  
  
 
   
  
 
 
  
 
   
 
      
  
  
     
 
  
      
     
       
  
the periosteum around the fracture site, and we were careful to cauterize the periosteum
only once to prevent excess thermal necrosis of bone. The wound was then irrigated with 
10 cc of sterile saline and the wound was dried with gauze.
The rats were randomized to receive one of two treatments. One group was treated with 
100 mg rhBMP-7 in 25 μL of 50 mM acetic acid containing 3 mg/mL rat tail tendon collagen
(BMP-7 group), and the other group was treated with 25 μL of 50 mM acetic acid
containing 3 mg/mL rat tail tendon collagen (control group). The rhBMP-7 or the collagen
buffer alone was carefully applied anteriorly, laterally, and posteriorly to the experimental 
non-union site with a pipet. The viscosity of the collagen buffer prevented extravasation 
into the surrounding soft tissues. The muscle fascia and skin were closed in layers with 5-0
nylon sutures. Post-operative pain was managed by subcutaneous adminis-tration of
buprenorphine hydrochloride. The rats were fed a standard maintenance diet and provided
water ad libitum. Unprotected weight bearing was allowed immediately postoperatively.
Eight animals were assigned to each group and were maintained for intervals of 3 and 6
weeks. Five specimens from each group were randomly selected for biomechanical testing 
at 3 and 6 weeks. The three remaining specimens from each group were processed for 
histologic examination. Nine animals initially operated on for the study were replaced with 
animals of like age. Eight animals (6 in the old group, 2 in the young group) were excluded
because the fracture produced was not a simple transverse fracture, and one young animal 
died from an anesthetic complication. This research protocol was approved by the 
Institutional Animal Care and Use Committee.
Radiological Evaluation
The progress of bone formation was monitored on radiographs taken with a Faxitron 
imaging device (model 43855A; Faxitron X-ray, Buffalo Grove, IL). Radiographs of all rats 
were obtained immediately after surgery and at 3 and 6 weeks. This was done under 
anesthesia with the animal prone and with both limbs fully abducted and externally
rotated. Fracture union was determined by the presence of bridging callus on two cortices.
Radiographs of each animal were assessed by three blinded independent observers to 
judge whether the fractures united or not. When the reviewers differed in their
interpretation, the classification of healed versus not healed was made by group consensus.
Histological Evaluation
Three rats from each group were utilized for histological evaluation. After euthanasia, the 
right femurs were harvested and fixed in 4% paraformaldehyde in 0.1M phosphate buffer
for 24 h at 4°C, defatted in 70% ethanol, decalcified with 10% formic acid in citrate for 4 
days at 4°C, and embedded in paraffin. Paraffin sections 4 mm thick were cut and stained
with toluidine blue for histological evaluation.
  
 
  
   
   
          
      
  
  
  
   
 
     
   
 
  
 
  
   
   
 
  
  
    
  
  
      
     
 
 
 
Biomechanical Evaluation
Five animals from each group were used for biomecha-nical evaluation. Following
euthanasia the right femurs and the contralateral nonfractured intact femurs were 
harvested and dissected free of surround-ing muscles. After removal of the intramedullary
K wires, the ends of both femurs were imbedded in Wood’s metal (Alfa Aesar, Ward Hill,
MA). Specimen lengths were not statistically different between the young control group
(19.4 士 3.2 mm), the young BMP-7 group (19.0 士 2.9 mm), the old control group (22.0 士
2.0 mm), and the old BMP-7 group (21.9 士 1.9 mm). The speci-mens were mounted in a
Frankel–Burstein axial torsion-testing machine that was modified to operate under 
computer control.8 The standard swinging-pendulum mechanism was replaced with an 
electronic stepper motor drive (model 083062-1-8-031-010, Parker Compumotor, Rohnert 
Park, CA). Rotational displacement was measured with a precision potentiometer (model 
793341-14092, Gould. Inc., Cleveland, OH). Torque was measured with a 100 in. oz. torque 
cell (model 2105, Eaton Corporation, Troy, MI). Specimens were tested in torsion at a rate 
of 50° per minute until failure or through an arc of 45°. Rotational displacement and
torque data were collected at 60 Hz using a digital data acquisition system (model K500A,
Keithley Instru-ments, Cleveland, OH). Maximum torque to failure was measured directly
from the data and torsional stiffness was calculated from a regression of the linear portion 
of the torque versus angular displacement curve. The energy absorption to maximum 
torque was also calculated as the area under the curve to the maximum value. The 
nonfractured contralateral intact femur was also tested to calculate normalized values of
maximum torque to failure (percentage maximum torque), stiffness (percentage stiffness),
and energy absorption to maximum torque (percentage energy) in order to reduce the 
influence of individual animal differences.
Statistical Analysis
A two-factor analysis of variance (ANOVA) was per-formed on the normalized data of the
biomechanical properties to account for individual animal differences at each time point 
(3 weeks and 6 weeks). The factors were animal age (young and old group) and treatment
(BMP-7 group and control group). A two-factor ANOVA was also performed on the actual 
values of the biomechanical properties. The factors used were young, old, BMP treated,
and intact. Significance was defined as p values less than 0.05. When appropriate, a 
Bonferroni–Dunn post hoc test was performed to determine differences between the 
factors at each time point.
RESULTS
Radiological Evaluation
    
    
 
 
   
  
 
 
   
    
 
  
    
 
  
      
     
 
 
   
 
   
 
 
 
 
    
   
 
In the 3-month-old animals, all of the rhBMP-7–treated animals were radiographically
healed by 3 weeks. In contrast, only 56% (9/16) of the rhBMP-7–treated 18-month-old
animals were radiographically healed at 3 weeks. At 6 weeks, all (8/8) of the older animals 
achieved radio-graphic union. In both age groups, none of the control animals healed
throughout the 6 weeks of experimental duration.
In the young animals the BMP-7 group dis-played abundant callus around the 
fracture sites at 3 weeks (Fig. 1C). At 6 weeks the callus size had decreased, indicating 
ongoing remodeling (Fig. 1D). In the older animals, the BMP-7 group also showed callus 
formation at 3 weeks (Fig. 1G), but it was less robust than in the younger animals (Fig.
1C). At 6 weeks, the size of the callus conti-nued to increase in the older animals (Fig. 1H). 
No significant callus was seen in either the young or old animals in the control group (Fig.
1A,B,E,F). Some callus formed along the periosteum away from the fracture site, but this 
never extended to bridge the fracture site and a fracture gap still persisted at 6 weeks 
(Fig. 1B,F).
Histological Evaluation
At three weeks, the 3-month-old rhBMP-7– treated group displayed an abundant callus 
formation. Newly formed trabecular bone was the predominant component of this 
callus. The bony union was less than complete due to the presence of a small amount of
cartilage in the callus (Fig. 2C). At 6 weeks, a complete bony union was achieved and the 
united bone had remodeled as shown by a decrease in the overall diameter of the woven
bone (Fig. 2D). The 18-month-old rhBMP-7–treated group displayed bridging
cartilaginous tissue at 3 weeks (Fig. 2G). There was a cartilage plate uniting the bony 
fragments and a few remaining fibrous elements in the fracture gap. Increasing
ossification was observed at 6 weeks, however a small amount of cartilaginous elements 
remained within the cal-lus (Fig. 2H).
The control groups of both young and old groups (Fig. 2A,B,E,F) exhibited some 
nonbridging endo-chondral ossification, however, there was no bone formation at the 
site of periosteal cauterization. A large gap persisted between the fractured bony 
fragments even at 6 weeks. Fibrous tissue interposition was observed at the fracture 
site. Neither bony nor cartilaginous bridging was seen in the control group at either time 
point.
Biomechanical Evaluation
The means and standard deviations of the maximum torque to failure, the stiffness, and the 
energy absorption to maximum torque are shown in Table 1. Significant increases in all the 
mechanical properties were seen in the rhBMP-7–treated animals compared to the control
ani-mals at each time point in both young and old age groups. When we compared the raw
  
   
           
  
   
         
   
  
   
   
   
 
    
            
 
    
  
   
   
     
 
 
  
 
    
     
  
  
      
  
 
  
    
values of the rhBMP-7–treated animals with the intact bones at 3 weeks, the values for the 
old group of rhBMP-7–treated animals were significantly less than the intact bones in 
maximum torque ( p < 0.0001) and stiffness ( p < 0.0001), while there were no significant
differences in the young group at 3 weeks. As for energy at 3 weeks, the values of the
rhBMP-7–treated animals were significantly less than the intact bones both in the young (
p = 0.004 1) and old ( p < 0.0001) groups. No significant differences were observed at 6
weeks for the young or old groups. The mechanical properties of the control animals 
remained low in both age groups, indicating development of a nonunion.
To account for variation in animal size, the maximum torque, stiffness, and energy
absorption values were also normalized by the respective values of the contralateral intact
femurs (percen-tage maximum torque, percentage stiffness, and percentage energy) and
average values were calculated for each group (Fig. 3). When we compared the young
rhBMP-7 group to the old rhBMP-7 group, we found significant differences in percentage 
maximum torque ( p = 0.0066) and percentage stiffness ( p = 0.0004) at 3 weeks, and no 
significant differences at 6 weeks.
All the mechanical properties of the rhBMP-7– treated animals increased between 3 and
6 weeks in both age groups with the exception of the percentage stiffness of the young
rhBMP-7 group at 3 weeks. The percentage stiffness of the young BMP-7 group already
exceeded the stiffness of the intact femur at 3 weeks. At 6 weeks the per-centage maximum
torque and percentage energy of the 18-month-old rhBMP-7–treated animals
exceeded 100%, and the percentage stiffness was 97%.
DISCUSSION
The rate of fracture healing is known to slow with increasing age, but the reason for this
deceleration is unknown. The periosteum in child-ren, whose fracture healing is relatively
rapid, has a higher cellular and vascular activity. This diminishes with age and older 
patients display slower cell differentiation.
Few previous in vivo studies have examined fracture healing in aged animals.9–12 In a
standard stabilized femur fracture model, younger rats heal more rapidly than older rats.
Mechanical strength was restored within 4 weeks in 8-week-old rats, compared with 12
weeks in 32-week-old rats. Meanwhile 50-week-old rats had still not regained their full
mechanical strength 24 weeks following fracture.13 
Bone induction by both demineralized bone matrix and BMPs has been shown to be
decreased in older rats compared to young rats. Reddi reported a significant decline in the 
osteoinductive potential of bone matrix derived from 24-month-old rats compared to 4­
month-old rats.14 Fleet and colleagues, using an ectopic bone formation model, reported
     
 
 
 
   
   
   
   
  
   
    
 
 
   
  
  
 
      
    
   
 
  
 
 
   
      
   
   
  
 
 
    
  
    
that aging blunts rhBMP-2–induced bone formation in rats.15 They demonstrated a rapid
decline in BMP-induced bone formation between the 3-week and 3-month animals, and a 
further decline between 3 months and 16 months.
Several explanations for the blunted response to BMP in older animals have been 
proposed. Older mice have been shown to have a smaller number of osteogenic precursor
cells and this may limit fracture repair.16 Other studies have shown that the chondrogenic 
and osteogenic potential of osteoprogenitor cells decrease with increasing age.16,17 Shih and
colleagues reported that a reduction in osteoblast recruitment, rather than a reduced
capacity to form bone, accounts for the age-related decrease in bone formation.18 Fleet and
colleagues proposed that a lower level of circulating or local anabolic agents in older 
animals may result in fewer available BMP-responsive cells.15 Following treatment with 
either growth hormone or 1,25-dihydroxyvitamin D3, Fleet and colleagues reported that
BMP-induced bone formation in 16-month-old rats returned to that seen in 3-month-old
rats. In addition they found that the age-related decline in bone formation could be
minimized by increas-ing the amount of rhBMP-2 administered or by extending the length 
of time the osteoconductive implants were allowed to remain in place.15 There may also be
a deficit of BMP receptors in older animals compared to younger animals. Meyer and
colleagues have investigated whether differential expression of various cytokines is a 
possible explanation for delayed fracture healing seen in aged animals.19–21 They found that
osteocalcin, type I and II collagen, BMP-2, BMP-4, and type IA BMP receptor were 
upregulated following fracture in both young (6 week) and old (12–15 month) rats.21 In the 
young rats there was elevated gene expression until fracture healing had occurred, while in 
the older rats the gene expression returned to baseline prior to complete fracture healing.
The results of these studies suggest that the age-related impairment in fracture healing is 
not due to the lack of expression of the various growth factors studied. In addition, the 
slower healing in older rats did not stimulate a negative-feedback upregulation in gene
expression of the various stimulatory cytokines. 19–21 
Aronson reported decreased bone formation in older animals in a distraction 
osteogenesis model in the rat tibia.22 They found a significant reduc-tion in bone formation 
in the regenerate bone in 24- month-old rats compared to 9-month-old rats (51% vs. 68%).
When 24-month-old rats were compared with 3-month-old rats, the reduction was even
greater (34% vs. 95%). They reported that the periosteal new bone formation was similar
in the old and young rats, but the endosteal bone formation was reduced in the older 
animals.
The possible role for growth factors other than BMP has been examined in aged animal 
models. Aronson examined the effect of rhFGF administration in old and young rats.
Histologically the old rat controls had significantly less endosteal new bone formation than 
the young rat controls. The old rats treated with rhFGF had significantly increased
    
    
     
  
    
   
      
   
 
     
  
 
    
  
    
   
   
 
     
     
  
    
   
         
 
 
  
 
     
 
  
  
  
endosteal new bone compared to the old rat controls.9 Blumenfeld and colleagues
examined the effect of transforming growth factor 13 (TGF-13) and insulin-like growth
factor-1 (IGF-1) in a unicortical bone defect in aged rats. They found that TGF-13 and IGF-1
administered individually improved fracture healing and that the combination of TGF-13
and IGF-1 had a synergistic effect in healing of the bone defect.11 
We have developed a reproducible rat femoral non-union model.23 This model was
specifically developed to better simulate the altered biological environment that is seen in
high energy fractures in which there is severe perisoteal damage leading to non-union
formation. Clinical and experimental evidence indicates that periosteal disruption at the 
fracture site impairs fracture healing.24–26 Even in young 3-month-old rats the severe
periosteal damage created in this model impedes normal fracture healing.
We have previously shown that immediate administration of 50 μg rhBMP-7 to the 
fracture site can restore the normal fracture healing process in young 3-month-old rats.27
In the current study we demonstrated that the immediate appli-cation of rhBMP-7 can also 
restore the healing process in aged animals. Because of the reported blunted effect of BMP 
response in older animals, we increased the BMP dose from the 50 μg we used in younger 
animals to 100 μg in this study. We did not, however, test the lower BMP dose in the older 
animals in this study. The ability of rhBMP-7 to stimulate bone formation in older animals 
is important because of the increasing numbers of fractures sustained in older patients.
While not dramatic, the healing rate in the older animals was slowed, even in the 
presence of rhBMP-7 administration. Serial radiographs indicated that all of the rhBMP-7– 
treated younger animals healed by 3 weeks, while only 56% of the older animals had
united radiographically at 3 weeks. The mechanical results also demonstrated slower 
restoration in the older animals. In the older animals, the actual maximum torque ( p <
0.0001) and stiffness ( p = 0.0001) values of the rhBMP-7–treated group were
significantly less than the intact bones at 3 weeks, while there were no significant 
differences in the younger animals at this time point. At 6 weeks there were no significant
differences between the BMP-treated groups and the intact bone in either age group.
In conclusion, the present study demonstrates that the immediate application of rhBMP­
7 has the potential to accelerate fracture healing in older animals with impaired fracture 
healing, even in the presence of significant periosteal damage. However, the effect of
rhBMP-7 on the rate of fracture healing is greater in young rats compared to old rats.
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 1. Radiographs ofthe youngcontrol group (A, B), the young rhBMP-7 group (C,
D), the old control group (E, F), and the old rhBMP-7 group (G, H) obtained at 3 weeks
after surgery (A, C, E, G) and 6weeks after surgery (B, D, F, H). Note the abundant callus
at 3 weeks (C) and the reduced amounts of callus at 6 weeks (D) in the young rhBMP-7
group. On the otherhand, more abundant callus is observedat 6weeks (H) thanat 3weeks
(G) in the old rhBMP-7 group. Atrophic non-union developments are seen at 6 weeks in
the control group of both young and old (B, F).
 2. Histological findings ofthe young control group (A, Bl, the young rhBMP-?
group (C, Dl, the oldcontrol group (E, Fl, and the old rhBMP-? group (G, H). Sectionswere
stained with toluidine hlue. The young rhBMP-? group at 3 weeks displayed an
incomplete hony union (Cl, and a complete hony union at 6 weeks (Dl. The old rhBMP-?
group displayed a cartilaginous union at 3 weeks (Gl, and an incomplete hony union at
6weeks (Hl. Control groupsohtained neither bonynor cartilaginousunion eventhough at
6 weeks. Bar = 1 mm.
  
 
 
 
 
 
 
 
 
 
 
Table 1. Mechanical Test Results of 3-Month-Old and 18-Month-Old Animals
Intact Control BMP-7
18-month-old animals
Maximum torque to failure (nm)
3-month-old animals 3 weeks 0.295 ± 0.037 0.015 ± 0.009 0.239 ± 0.020
6 weeks 0.421 ± 0.039 0.028 ± 0.014 0.418 ± 0.049
3 weeks 0.425 ± 0.142 0.033 ± 0.030 0.285 ± 0.073
6 weeks 0.471 ± 0.169 0.072 ± 0.057 0.493 ± 0.081
Stiffness (nm/rad)
3-month-old animals
18-month-old animals
Energy absorption to maximum
torque (nm rad)
3-month-old animals
18-month-old animals
3 weeks 1.198 ± 0.240 0.036 ± 0.030 1.115 ± 0.088
6weeks 1.747±0.202 0.070±0.053 1.826±0.247
3 weeks 2.353 ± 0.341 0.050 ± 0.031 1.492 ± 0.348
6 weeks 2.608 ± 0.443 0.286 ± 0.222 2.151 ± 0.392
3 weeks 0.044 ± 0.005 0.002 ± 0.002 0.029 ± 0.004
6 weeks 0.057 ± 0.009 0.004 ± 0.003 0.066 ± 0.014
3 weeks 0.049 ± 0.029 0.006 ± 0.005 0.028 ± 0.011
6 weeks 0.058 ± 0.043 0.007 ± 0.006 0.083 ± 0.037
Figure 3. Biomechanical properties of the rhBMP-7 group and the control group in
both young and old groups normalized by the respective values of the intact femurs. (A)
Percentage maximum torque (maximum torque to failure of fractured femur/non­
fractured intact femur x 100). (B) Percentage stiffness (stiffness of fractured femur/
nonfractured intact femur x 100). (C) Percentage energy (energy absorption to maximum
torque/nonfractured intact femur x 100). Significant increases in all the mechanical
properties were seen in the rhBMP-7 group compared to the control at each time points
both inyoung and old groups. Comparing theyoungrhBMP-7 group and the old rhBMP-7
group, we found significant differences in percentage maximum torque (p = 0.0066) and
percentage stiffness (p = 0.0004) at 3 weeks, and no significant differences at 6 weeks.
*p < 0.01, **p < 0.001, ***p < 0.0001.
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Figure 3.
